High-glucose-based peritoneal dialysis solution induces the upregulation of VEGF expression in human peritoneal mesothelial cells: The role of pleiotrophin

International Journal of Molecular Medicine

Volumn 32, Issue 5, 2013, Pages 1150-1158

  Liu, Jia ^a   Wu, Xia ^a   Liu, Yanchun ^a   Xu, Yaguang ^a   Huang, Yuhan ^a   Xing, Changying ^a   Wang, Xiaoyun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Extracelluar signal regulated kinase; Fluvastatin; High glucose peritoneal dialysate; Human peritoneal mesothelial cells; Pleiotrophin; Serum and glucocorticoid inducible kinase 1; Vascular endothelial growth factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FLUINDOSTATIN; GLUCOSE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLEIOTROPHIN; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; VASCULOTROPIN;

ARTICLE; CELL STRUCTURE; CELL VIABILITY; COLORIMETRY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; MESOTHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RENAL PROTECTION; SIGNAL TRANSDUCTION; UPREGULATION;

CARRIER PROTEINS; CELL LINE; CELL SURVIVAL; CYTOKINES; GLUCOSE; HUMANS; PERITONEAL CAVITY; PERITONEAL DIALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885036281     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1491     Document Type: Article

References (35)

1. He Z, Potter R, Li X and Flessner M: Stretch of human mesothelial cells increases cytokine expression. Adv Perit Dial 28: 2-9, 2012.
2. Loureiro J, Aguilera A, Selgas R., et al.: Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage: J Am Soc Nephrol 22: 1682-1695, 2011.
3. Mizutani M, Ito Y, Mizuno M., et al.: Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol 298: F721-F733, 2010.
4. Yokoi H, Kasahara M, Mori K., et al.: Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3, 4-didexoxyglucosone-3-ene in mice. Perit Dial Int 33: 143-154, 2013.
5. Heimbürger O., Waniewski J, Werynski A., et al.: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38: 495-506, 1990.
6. Davies SJ, Phillips L, Naish PF and Russell GI: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12: 1046-1051, 2001.
7. Plum J, Hermann S, Fussholler A., et al.: Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int Suppl 78: S42-S47, 2001.
8. Zweers MM, de Waart DR, Smit W, et al.: Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med 134: 124-132, 1999
9. Zweers MM, Struijk DG, Smit W and Krediet RT: Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up. J Lab Clin Med 137: 125-132, 2001.
10. Milner PG, Li YS, Hoffman RM, et al.: A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence. Biochem Biophys Res Commun 165: 1096-1103, 1989
11. Rauvala H: An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors. EMBO J 8: 2933-2941, 1989
12. Deuel TF, Zhang N, Yeh H.J., et al.: Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 397: 162-171, 2002.
13. Kohashi T, Tateaki Y, Tateno C., et al.: Expression of pleiotrophin in hepatic nonparenchymal cells and preneoplastic nodules in carbon tetrachloride-induced fibrotic rat liver. Growth Factors 20: 53-60, 2002.
14. Henger A, Kretzler M, Doran P, et al.: Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. Kidney Int 65: 904-917, 2004
15. Yokoi H, Kasahara M, Mori K., et al.: Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis. Kidney Int 81: 160-169, 2012.
16. Jorres A and Witowski J: PD membrane: biological responses to different PD fluids. Contrib Nephrol 150: 48-53, 2006.
17. Vrtovsnik F, Coester AM, Lopes-Barreto D, et al.: Induction of chronic kidney failure in a long-term peritoneal exposure model in the rat: effects on functional and structural peritoneal alterations. Perit Dial Int 30: 558-569, 2010.
18. De Vriese A.S., Mortier S and Lameire NH: Glucotoxicity of the peritoneal membrane: the case for VEGF. Nephrol Dial Transplant 16: 2299-2302, 2001.
19. Szeto CC, Wong TY, Lai K.B., et al.: The role of vascular endo-thelial growth factor in peritoneal hyperpermeability during CAPD-related peritonitis. Perit Dial Int 22: 265-267, 2002.
20. Kong Y, Bai PS, Nan K.J., et al.: Pleiotrophin is a potential colorectal cancer prognostic factor that promotes VEGF expression and induces angiogenesis in colorectal cancer. Int J Colorectal Dis 27: 287-298, 2012.
21. Saad S, Stevens VA, Wassef L, et al.: High glucose transactivates the EGF receptor and up-regulates serum glucocorticoid kinase in the proximal tubule. Kidney Int 68: 985-997, 2005.
22. Waldegger S, Barth P, Raber G and Lang F: Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations of cell volume. Proc Natl Acad Sci USA 94: 4440-4445, 19 9 7.
23. Firestone GL, Giampaolo JR and O'Keeffe BA: Stimulus-dependent regulation of serum and glucocorticoid inducible protein kinase (SGK) transcription, subcellular localization and enzymatic activity. Cell Physiol Biochem 13: 1-12, 2003.
24. Lang F and Cohen P: Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms. Sci STKE 2001: re17, 2001.
25. Waerntges S, Klingel K, Weigert C., et al.: Excessive transcription of the human serum- and glucocorticoid dependent kinase hSGK1 in lung fibrosis. Cell Physiol Biochem 12: 135-142, 2002.
26. Fillon S, Klingel K, Warntges S., et al.: Expression of the serine/ threonine kinase hSGK1 in chronic viral hepatitis. Cell Physiol Biochem 12: 47-54, 2002.
27. Roskoski R Jr: ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res 66: 105-143, 2012.
28. Zhu P, Ren M, Yang C., et al.: Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes. Exp Dermatol 21: 123-129, 2012.
29. Vasan RS, Sullivan LM, Roubenoff R, et al.: Inflammatory markers and the risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham heart study. Ci r culation 10 7: 1486-1491, 20 03.
30. Yokota T, Utsunomiya K, Murakawa Y., et al.: Mechanism of preventive effect of HMG-CoA reductase inhibitor on diabetic nephropathy. Kidney Int Suppl 71: S178-S181, 1999.
31. Hayashi M, Tapping RI, Chao T.H., et al.: BMK1 mediates growth factor-induced cell proliferation through direct cellular activation of serum and glucocorticoid-inducible kinase. J Biol Chem 276: 8631-8634, 2001.
32. Mizuno H and Nishida E: The ERK MAP kinase pathway mediates induction of SGK (serum- and glucocorticoid-inducible kinase) by growth factors. Genes Cells 6: 261-268, 2001.
33. Meng F, Yamagiwa Y, Taffetani S., et al.: IL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway. Am J Physiol Cell Physiol 289: C971-C981, 20 05.
34. Shelly C and Herrera R: Activation of SGK1 by HGF, Rac1 and integrin-mediated cell adhesion in MDCK cells: PI-3K-dependent and -independent pathways. J Cell Sci 115: 1985-1993, 2002.
35. Prasad N, Topping RS, Zhou D and Decker SJ: Oxidative stress and vanadate induce tyrosine phosphorylation of phosphoinositide-dependent kinase 1(PDK1). Biochemistry 39: 6929-6935, 2000.